Results 41 to 50 of about 4,714 (209)

Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response

open access: yesFrontiers in Endocrinology, 2021
ObjectiveTo compare the clinical outcomes of dydrogesterone (DYG) and medroxyprogesterone (MPA) in the progestin-primed ovarian stimulation (PPOS) protocol for patients with poor ovarian response (POR).Patients and MethodsThis was a retrospective cohort ...
Junwei Zhang   +6 more
doaj   +1 more source

Breast cancer risk associated with different HRT formulations: a register-based case-control study [PDF]

open access: yes, 2006
Background Previous epidemiological studies have inconsistently shown a modestly increased breast cancer risk associated with hormone replacement therapy (HRT).
Juergen C Dinger   +42 more
core   +2 more sources

Successful pregnancy: simply about the complicated

open access: yesРепродуктивная эндокринология
Progesterone is a key hormone essential for maintaining pregnancy. Its deficiency can lead to the risk of miscarriage, recurrent pregnancy loss, and unsuccessful attempts at in vitro fertilization.
T.F. Tatarchuk   +4 more
doaj   +1 more source

Additional dydrogesterone for the treatment of chronic endometritis treated with antibiotic in premenopausal women with endometrial polyps: a retrospective cohort study

open access: yesBMC Women's Health, 2022
Background To assess the efficacy of dysdrogesterone in the treatment of chronic endometritis (CE) treated with antibiotic in premenopausal women with endometrial polyps (EPs).
Yue Liu   +6 more
doaj   +1 more source

FIGO best practice recommendations for the mental health of women at menopausal age

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Mental health during the menopausal transition requires focused attention to ensure supportive experiences for women. This review presents the International Federation of Gynecology and Obstetrics (FIGO) recommendations and summarizes the evidence, addressing 13 key questions framed by members of the FIGO Committee on Women at Menopausal Age ...
Suvarna Khadilkar   +10 more
wiley   +1 more source

Comparative study of dydrogesterone dosage of the duphaston 40mg daily and duphaston 20mg daily in the outcome of pregnancy with threatened miscarriage in husm. [PDF]

open access: yes, 2011
Objective To evaluate the effectiveness and the adverse effect of Duphaston 40mg daily and Duphaston 20mg daily in threatened miscarriage. Methodology This is a prospective randomized controlled trial conducted at Hospital USM, Kubang Kerian Kelantan ...
Abd Rahim, Rahimah
core  

Risk of Cancer With Hormone Replacement Therapy: A Narrative Review

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Hormone replacement therapy (HRT) remains the cornerstone of menopausal symptom management, effectively alleviating vasomotor symptoms and genitourinary syndrome, whilst mitigating long‐term risks such as osteoporosis. However, despite an increasing body of evidence on the relative safety of HRT, earlier studies that demonstrated an increased ...
Gabriella Yongue   +3 more
wiley   +1 more source

Comparison of pregnancy outcome after adding oral or intramuscular progesterone to vaginal progesterone in frozen embryo transfer: A cross-sectional study

open access: yesInternational Journal of Reproductive BioMedicine
Background: Currently, frozen embryo transfers (FET) account for 41% of all embryo transfer cycles. Vaginal progesterone preparations have become the leading choice for luteal phase support due to their convenient application; however, using only ...
Sahereh Arabian   +4 more
doaj   +1 more source

Resolution of the First Ukrainian endometriosis forum “Drug treatment for endometriosis-associated pelvic pain. The quality of a woman’s life”

open access: yesРепродуктивная эндокринология, 2023
Endometriosis affects 10% of all women of reproductive age, i.e. 190 million patients. Ukraine currently does not gather statistics on the incidence of endometriosis, but, at a rough estimate, this number is approximately 280 thousand women and the real ...
A.V. Boichuk   +11 more
doaj   +1 more source

Hormone Replacement Therapy for Menopausal Symptoms and the Risk of Cardiometabolic Disease: Current Evidence and Future Directions

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background The transition through menopause is accompanied by a series of adverse metabolic changes which are associated with an increased risk of cardiometabolic disease, a major cause of mortality in women after midlife. Whilst the indication for menopausal hormone replacement therapy (HRT) is the control of menopausal symptoms ...
Jiawen Dong   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy